Cargando…

Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket

[Image: see text] Sirtuins (SIRTs) are NAD-dependent deacylases, known to be involved in a variety of pathophysiological processes and thus remain promising therapeutic targets for further validation. Previously, we reported a novel thienopyrimidinone SIRT2 inhibitor with good potency and excellent...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundriyal, Sandeep, Moniot, Sébastien, Mahmud, Zimam, Yao, Shang, Di Fruscia, Paolo, Reynolds, Christopher R., Dexter, David T., Sternberg, Michael J. E., Lam, Eric W.-F., Steegborn, Clemens, Fuchter, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014686/
https://www.ncbi.nlm.nih.gov/pubmed/28135086
http://dx.doi.org/10.1021/acs.jmedchem.6b01690
_version_ 1783334274192113664
author Sundriyal, Sandeep
Moniot, Sébastien
Mahmud, Zimam
Yao, Shang
Di Fruscia, Paolo
Reynolds, Christopher R.
Dexter, David T.
Sternberg, Michael J. E.
Lam, Eric W.-F.
Steegborn, Clemens
Fuchter, Matthew J.
author_facet Sundriyal, Sandeep
Moniot, Sébastien
Mahmud, Zimam
Yao, Shang
Di Fruscia, Paolo
Reynolds, Christopher R.
Dexter, David T.
Sternberg, Michael J. E.
Lam, Eric W.-F.
Steegborn, Clemens
Fuchter, Matthew J.
author_sort Sundriyal, Sandeep
collection PubMed
description [Image: see text] Sirtuins (SIRTs) are NAD-dependent deacylases, known to be involved in a variety of pathophysiological processes and thus remain promising therapeutic targets for further validation. Previously, we reported a novel thienopyrimidinone SIRT2 inhibitor with good potency and excellent selectivity for SIRT2. Herein, we report an extensive SAR study of this chemical series and identify the key pharmacophoric elements and physiochemical properties that underpin the excellent activity observed. New analogues have been identified with submicromolar SIRT2 inhibtory activity and good to excellent SIRT2 subtype-selectivity. Importantly, we report a cocrystal structure of one of our compounds (29c) bound to SIRT2. This reveals our series to induce the formation of a previously reported selectivity pocket but to bind in an inverted fashion to what might be intuitively expected. We believe these findings will contribute significantly to an understanding of the mechanism of action of SIRT2 inhibitors and to the identification of refined, second generation inhibitors.
format Online
Article
Text
id pubmed-6014686
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-60146862018-06-25 Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket Sundriyal, Sandeep Moniot, Sébastien Mahmud, Zimam Yao, Shang Di Fruscia, Paolo Reynolds, Christopher R. Dexter, David T. Sternberg, Michael J. E. Lam, Eric W.-F. Steegborn, Clemens Fuchter, Matthew J. J Med Chem [Image: see text] Sirtuins (SIRTs) are NAD-dependent deacylases, known to be involved in a variety of pathophysiological processes and thus remain promising therapeutic targets for further validation. Previously, we reported a novel thienopyrimidinone SIRT2 inhibitor with good potency and excellent selectivity for SIRT2. Herein, we report an extensive SAR study of this chemical series and identify the key pharmacophoric elements and physiochemical properties that underpin the excellent activity observed. New analogues have been identified with submicromolar SIRT2 inhibtory activity and good to excellent SIRT2 subtype-selectivity. Importantly, we report a cocrystal structure of one of our compounds (29c) bound to SIRT2. This reveals our series to induce the formation of a previously reported selectivity pocket but to bind in an inverted fashion to what might be intuitively expected. We believe these findings will contribute significantly to an understanding of the mechanism of action of SIRT2 inhibitors and to the identification of refined, second generation inhibitors. American Chemical Society 2017-01-30 2017-03-09 /pmc/articles/PMC6014686/ /pubmed/28135086 http://dx.doi.org/10.1021/acs.jmedchem.6b01690 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Sundriyal, Sandeep
Moniot, Sébastien
Mahmud, Zimam
Yao, Shang
Di Fruscia, Paolo
Reynolds, Christopher R.
Dexter, David T.
Sternberg, Michael J. E.
Lam, Eric W.-F.
Steegborn, Clemens
Fuchter, Matthew J.
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket
title Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket
title_full Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket
title_fullStr Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket
title_full_unstemmed Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket
title_short Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket
title_sort thienopyrimidinone based sirtuin-2 (sirt2)-selective inhibitors bind in the ligand induced selectivity pocket
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014686/
https://www.ncbi.nlm.nih.gov/pubmed/28135086
http://dx.doi.org/10.1021/acs.jmedchem.6b01690
work_keys_str_mv AT sundriyalsandeep thienopyrimidinonebasedsirtuin2sirt2selectiveinhibitorsbindintheligandinducedselectivitypocket
AT moniotsebastien thienopyrimidinonebasedsirtuin2sirt2selectiveinhibitorsbindintheligandinducedselectivitypocket
AT mahmudzimam thienopyrimidinonebasedsirtuin2sirt2selectiveinhibitorsbindintheligandinducedselectivitypocket
AT yaoshang thienopyrimidinonebasedsirtuin2sirt2selectiveinhibitorsbindintheligandinducedselectivitypocket
AT difrusciapaolo thienopyrimidinonebasedsirtuin2sirt2selectiveinhibitorsbindintheligandinducedselectivitypocket
AT reynoldschristopherr thienopyrimidinonebasedsirtuin2sirt2selectiveinhibitorsbindintheligandinducedselectivitypocket
AT dexterdavidt thienopyrimidinonebasedsirtuin2sirt2selectiveinhibitorsbindintheligandinducedselectivitypocket
AT sternbergmichaelje thienopyrimidinonebasedsirtuin2sirt2selectiveinhibitorsbindintheligandinducedselectivitypocket
AT lamericwf thienopyrimidinonebasedsirtuin2sirt2selectiveinhibitorsbindintheligandinducedselectivitypocket
AT steegbornclemens thienopyrimidinonebasedsirtuin2sirt2selectiveinhibitorsbindintheligandinducedselectivitypocket
AT fuchtermatthewj thienopyrimidinonebasedsirtuin2sirt2selectiveinhibitorsbindintheligandinducedselectivitypocket